Shasun Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 29, 2013, to consider the Audited Financial Results and to consider recommendation of dividend, if any for the financial year ended March 31, 2013.
The above information is a part of company’s filings submitted to BSE.